The rise of femtech is a result of the white space in healthcare catered exclusively for women and the growing interest from investors.
Women have historically been excluded as participants and decision makers in healthcare development, leading to gaps in knowledge about conditions affecting women.
To address this, a system-level investing approach is needed which involves informing traditional investors, hiring female medical experts, investing in female-led healthcare companies, and educating the public.
Femtech is not just a fad but an investable asset class with potential for disruption in the healthcare industry.